Medgend Icon







discontinued


Cipro FDA Approved Drugs

CETRAXAL [Ciprofloxacin HydrochlorideC17H18FN3O3ClHH2O]
RX
-
eq 0.2% base (otic solution/drops)
Wraser PharmsMay 1, 2009
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CILOXAN [Ciprofloxacin HydrochlorideC17H18FN3O3ClHH2O]
RX
-
eq 0.3% base (ophthalmic solution/drops)
Novartis Pharms CorpDec 31, 1990
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CIPRO [CiprofloxacinC17H18FN3O3]
RX
-
250mg/5ml (oral for suspension)
500mg/5ml (oral for suspension)
Bayer HlthcareSep 26, 1997
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CIPRO [Ciprofloxacin HydrochlorideC17H18FN3O3ClHH2O]
RX
-
eq 100mg base (oral tablet)
eq 250mg base (oral tablet)
eq 500mg base (oral tablet)
eq 750mg base (oral tablet)
Bayer HlthcareApr 8, 1996
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CIPRO HC [Ciprofloxacin HydrochlorideC17H18FN3O3ClHH2O : HydrocortisoneC21H30O5]
RX
-
eq 0.2% base : 1% (otic suspension/drops)
Novartis Pharms CorpFeb 10, 1998
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CIPRODEX [CiprofloxacinC17H18FN3O3 : DexamethasoneC22H29FO5]
RX
-
0.3% : 0.1% (otic suspension/drops)
Novartis Pharms CorpJul 18, 2003
  • Treatment of acute otitis externa.
  • Treatment of acute otitis media.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CIPROFLOXACIN [CiprofloxacinC17H18FN3O3]
RX
-
200mg/20ml (10mg/ml) (injection injectable)
250mg/5ml (oral for suspension)
400mg/40ml (10mg/ml) (injection injectable)
500mg/5ml (oral for suspension)
ClarisApr 29, 2008
Hikma FarmaceuticaDec 22, 2009
HospiraAug 28, 2006
Lupin LtdMar 5, 2014
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CIPROFLOXACIN EXTENDED RELEASE [CiprofloxacinC17H18FN3O3 : Ciprofloxacin HydrochlorideC17H18FN3O3ClHH2O]
RX
-
212.6mg : eq 287.5mg base (oral tablet, extended release)
425.2mg : eq 574.9mg base (oral tablet, extended release)
Anchen PharmsNov 27, 2007
Mylan Pharms IncMar 22, 2007
Dr Reddys Labs LtdMar 26, 2007
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CIPROFLOXACIN HYDROCHLORIDE [Ciprofloxacin HydrochlorideC17H18FN3O3ClHH2O]
RX
-
eq 0.3% base (ophthalmic solution/drops)
eq 100mg base (oral tablet)
eq 250mg base (oral tablet)
eq 500mg base (oral tablet)
eq 750mg base (oral tablet)
Akorn IncDec 11, 2008
Amring PharmsJan 16, 2008
Fdc LtdJun 30, 2008
Rising Pharms IncDec 13, 2006
TeligentJun 9, 2004
Watson Labs IncJan 21, 2005
Dr Reddys Labs LtdJun 9, 2004
MylanJun 25, 2007
Taro PharmFeb 18, 2005
ApotexNov 4, 2004
Aurobindo PharmaApr 26, 2007
CarlsbadJun 9, 2004
HikmaJun 9, 2004
Ivax Sub Teva PharmsJun 9, 2004
Sun Pharm Inds LtdJun 9, 2004
Unique Pharm LabsSep 10, 2004
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER [CiprofloxacinC17H18FN3O3]
RX
-
200mg/100ml (injection injectable)
400mg/200ml (injection injectable)
Acs Dobfar Info SaMar 18, 2008
ClarisMar 18, 2008
HospiraMar 18, 2008
Hikma FarmaceuticaNov 18, 2009
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

ESBRIET [PirfenidoneC12H11NO]
RX
-
267mg (oral tablet)
801mg (oral tablet)
Genentech IncJan 11, 2017
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

OTIPRIO [CiprofloxacinC17H18FN3O3]
RX
-
6% (60mg/ml) (otic injectable, suspension)
Otonomy IncDec 10, 2015
  • Treatment of otic infection or inflammation.
  • Treatment of pediatric patients with otitis media with effusion undergoing tympanostomy tube placement.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

OTOVEL [Ciprofloxacin HydrochlorideC17H18FN3O3ClHH2O : Fluocinolone AcetonideC24H30F2O6]
RX
-
eq 0.3% base : 0.025% (otic solution/drops)
Laboratorios SalvatApr 29, 2016
  • Treatment of acute otitis media.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.